FloQast
We're Hiring!
FloQast Company Growth, Stability & Outlook
What People Are Saying About FloQast
-
Strong Revenue Growth: ARR milestones—surpassing $100M in 2024 and $200M in January 2026—point to rapid scaling over roughly two years. Additional signals like repeated inclusion on fast‑growth lists and observed headcount expansion reinforce an expanding topline and organizational footprint.
-
Investor Backing & Capital Strength: A $100M Series E in April 2024 at about a $1.6B valuation provided resources to invest in product and go‑to‑market. Stated plans to fund enterprise and international expansion, alongside current scale above $200M ARR, underscore capital‑supported execution.
-
Market Expansion: Enterprise traction and international growth are emphasized, including stronger EMEA momentum, new offices in London and Sydney, and the largest customer to date in Germany’s healthcare sector. A strategic alliance with EY in 2026 further extends reach into large finance transformation programs.
